Delivery Order SPE2DE24DA017-SPE2D626F40TB
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to Arthrex Inc. for Fibertak shoulder products valued at $59,190.12 on January 26, 2026. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by January 29, 2026. This delivery order was issued without a set-aside designation, reflecting Arthrex's competitive standing in federal procurement. Performance will take place at the contractor's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $21,525.98 fixed-price delivery order to Arthrex Inc. for Fibertak shoulder products on January 7, 2026, with an ultimate completion date of January 12, 2026. This delivery order was issued without a set-aside designation and will be performed at Arthrex's Naples, Florida location. Arthrex, a leading manufacturer of minimally invasive orthopedic medical technologies and surgical instruments, serves as the prime contractor with no...
- The Defense Logistics Agency's Medical Supply Chain awarded a $22,277.89 delivery order to Arthrex Inc. on October 28, 2025, for Fibertak shoulder products, with an ultimate completion date of November 12, 2025. This delivery order operates under a fixed-price contract with economic price adjustment terms and carries no set-aside designation, reflecting Arthrex's competitive position in federal orthopedic procurement. The work will be performed at Arthrex's headquarters in Naples, Florida....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23.8K to Arthrex Inc. for Fibertak shoulder products under a fixed-price contract with economic price adjustment provisions. The delivery order, issued on December 9, 2025, with an ultimate completion date of December 12, 2025, carries no set-aside designation and will be performed at Arthrex's headquarters location in Naples, Florida. Arthrex Inc., a leading global manufacturer of minimally invasive...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded Arthrex Inc., headquartered in Naples, Florida, a delivery order valued at $36,697.31 for Fibertak shoulder products under a fixed-price contract with economic price adjustment provisions. The award, issued on January 8, 2026, with an ultimate completion date of January 13, 2026, carries no set-aside designation, reflecting Arthrex's established competitive position as a leading supplier of minimally invasive orthopedic medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,619.03 to Arthrex Inc. for KL 1.8 Fibertak shoulder products. The contract, awarded on November 14, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by November 19, 2025. This delivery order was issued without set-aside designation, reflecting Arthrex's competitive position as a primary supplier of orthopedic medical technologies to the federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a $29,075 fixed-price delivery order to Arthrex Inc. for Fibertak shoulder products, with completion targeted for December 8, 2025. This delivery order was issued without set-aside designation, reflecting Arthrex's established competitive position as a primary supplier of orthopedic medical technologies to the Department of Defense and Department of Veterans Affairs. The contract includes economic price adjustment provisions and is...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $7,268.70 for Fibertak shoulder surgical products. The contract, issued on July 14, 2025, with an ultimate completion date of July 28, 2025, is a fixed-price delivery order with economic price adjustment provisions. The work will be performed in Naples, Florida, and the award was made by the Defense Logistics Agency's Medical Supply Chain on...
- Arthrex Inc., a leader in minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $2,422.90 for FIBERTAK shoulder products by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment carries an ultimate completion date of August 18, 2025, and was executed on August 4, 2025. The contract was competitively awarded with no set-aside designation, reflecting Arthrex's strong...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $10,397.80 fixed-price delivery order with economic price adjustment to Arthrex Inc. for KL 1.8 Fibertak shoulder products. This delivery order, issued on November 5, 2025, with an ultimate completion date of November 10, 2025, represents a direct procurement under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) valued at approximately $471 million and effective through September 2029. The award...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F40TBDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,764.85 to Arthrex Inc. for Fibertak shoulder products on February 3, 2026, with completion targeted for February 6, 2026. This fixed-price contract with economic price adjustment carries no set-aside designation, reflecting the contractor's established competitive position in federal orthopedic procurement. The order will be performed at Arthrex's headquarters location in Naples, Florida. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million and effective through September 2029. The master contract authorizes procurement of a comprehensive range of orthopedic products and surgical technologies to support Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. Arthrex, a leading manufacturer of minimally invasive orthopedic surgical instruments, implants, and biologics, has demonstrated substantial federal contracting capability as a prime contractor supplying advanced solutions across multiple orthopedic surgical specialties. The Fibertak shoulder products being delivered under this order are among the company's established offerings supporting the federal healthcare enterprise's orthopedic surgical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 2/2/26 |